H.R. 2452
Referred to CommitteeTo amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.
Introduced 5/19/2015•114th Congress•House
Latest Action
Referred to the Subcommittee on Health.
5/22/2015 • House
Summary
This bill amends the Federal Food, Drug, and Cosmetic Act to revise the requirements for health care economic information that is provided to entities selecting drugs for coverage or reimbursement, such as formularies. The information must include a conspicuous and prominent statement describing the differences between the information and the labeling approved for the drug.
"Health care economic information" is an analysis that describes the economic consequences of the use of a drug. Such an analysis is no longer required to compare the use of the drug to another intervention or no intervention. An analysis that relates only to an indication for which the drug is not approved is not health care economic information.Introduced in House • 5/19/2015
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Drug safety, medical device, and laboratory regulationHealth information and medical records
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (3)
Party Breakdown
1
Democrats
2
Republicans
0
Independents
Sponsor
R[
Cosponsors (2)
R[
R[
Bill Journey
Originated in the House
Introduced
May 19, 2015
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House5/19/2015